COVID-19 patients respond positively to Gilead Sciences experimental drug

Shares of Gilead Sciences Inc’s shares jumped by 16% following news reports that its experimental drug remdesivir is proving to be effective in U.S. trials of patients who have been severely afflicted by the COVID-19 disease caused by the coronavirus. According to a report from medical news website STAT, a University of Chicago hospital participating…

Google partnering with Carnegie Mellon University to forecast Wuhan coronavirus spread

In a statement, Alphabet Inc’s Google disclosed, over the last three days, it had surveyed a few users on their health at the request of Carnegie Mellon University researchers who are aiming to forecast the spread of Wuhan coronavirus infections. Google’s Opinion Rewards app, which exchanges responses to surveys from Google and its clients for…